Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
56
NCT00980187
A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM
Phase: Phase 4
Role: Lead Sponsor
Start: Mar 31, 2008
Completion: Aug 31, 2010